Intellectual Property Office Home University of Cincinnati
News
Technologies
Issued US Patents
UC Technology Startups
Forms
Our Mission
IP Overview
Patents
Copyright
Licensing
Conflicts
Policies and Law
Annual Reports
Staff and Location
Contact Us
Links
UC Directory
IPO Home

Case Number 096050 - Laboratory Test to Aid in the Diagnosis of Multiple Sclerosis

Description:  Patients having several neurological diseases have been shown to have elevated levels of axonally-derived proteins (i.e. tau and neurofilament proteins) in cerebrospinal fluid (CSF) and in brain tissue. Three monoclonal antibodies (MAbs) recognizing CSF tau proteins were developed. The Mabs were found to label a ladder of 30 kD to 50 kD tau proteins in CSF from patients with disease states producing axonal damage such as head trauma or CNS tumor but not in CSF from controls. High levels of tau protein in CSF were shown to be diagnostic of axonal degeneration in head trauma. An ELISA assay was developed with these MAbs to aid in the diagnosis of patients with axonal damage.



Issued US Patent - US Patent 6,797,478

For more information please contact Ellen Monson at 513-558-5274 or geoffrey.pinski@uc.edu



Back to Technologies
 
Printer Friendly Version of Laboratory Test to Aid in the Diagnosis of Multiple Sclerosis - 096050









Copyright Information © Copyright 2004-2012 university of Cincinnati, Ohio. All rights reserved.